TTrialPathMatch Me to Trials
← Back to trials
RecruitingPerioral Wrinkles

Treatment of Perioral Wrinkles Using Topical Poly-L-lactic Acid and Microneedling Device

Eligible age

40–70 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The first goal of this clinical trial is to learn if topical application of PLLA in conjunction with a microneedling treatment works to treat perioral wrinkles in adults. The second goal is to see whether the application of topical PLLA is more effective before or after a microneedling treatment. The main questions it aims to answer are: * Is PLLA present within the MN channels from in vivo biopsy samples? * Is it safe to combine topical PLLA and MN in the treatment of perioral wrinkles, as determined by the incidence and severity of adverse events in healthy subjects? * Does overall aesthetic and skin texture improve in combining microneedling with topical PLLA in the treatment of mild to moderate perioral wrinkles? * Is it the treatment of topical PLLA more effective when applied before or after a microneedling treatment. Researchers will compare the application of PLLA before a microneedling treatment to a microneedling treatment with PLLA application after to see which treatment method is more effective. Participants will: \- receive 2 treatments spaced 4-6 weeks apart of topical PLLA and microneedling

Sponsor: Skincare Physicians of Chestnut Hill

You may qualify if…

  • Males and non-pregnant, non-lactating females 40-70 years of age
  • Fitzpatrick Skin Type I-IV
  • Wrinkle severity graded by the investigator (1-3 on Lemperle scale)
  • Able to provide written informed consent, understand and be willing to comply with all study related procedures and follow-up visits
  • Signed informed consent obtained before any study-specific procedure is performed.

You may not qualify if…

  • Lesions suspicious for any malignancy, actinic keratosis, melasma, vitiligo, cutaneous papules/nodules or active inflammatory lesions in the area to be treated
  • Tenderness in the treatment rea
  • History of keloid formation or hypertrophic scarring
  • History of trauma or surgery to the treatment area
  • Scar present in the areas to be treated
  • Silicone or synthetic material injections in the areas to be treated
  • Injection of fat, collagen, hyaluronic acid or other dermal fillers in the areas to be treated within the previous 12 months
  • History of treatment with dermabrasion or laser in the areas to be treated within the previous 12 months

Where it's recruiting

Massachusetts

Chestnut Hill

Source: ClinicalTrials.gov · NCT07225348 · last updated 2025-12-05